47X-15596-05341
1 vaccination
0 coded responses
13 check-ins
0 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 543 / WI
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-03
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-10
- 2021-05-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-03 | priority 2/3 | |
| 2021-04-04 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.